Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2020

Oct 9, 2020

35081_dirs_2020-10-09_1cc28a28-aa5a-4f66-9153-0ed42067a8a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2020-09-30

Reporting Person: FERNANDEZ FERNANDO L (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-09-30 Common Stock A 2968 Acquired 40644 Direct

Footnotes

F1: The award relates to vested restricted stock units ("RSUs") granted September 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (1) the two (2) year anniversary of the grant date; (3) the Reporting Person's separation from service; (3) a change in control, as defined in the Issuer's 2016 Equity Incentive Plan; or (4) the Reporting Person's death.